Security Snapshot

ALLERGAN PLC - SHS (AGN) Institutional Ownership

CUSIP: G0177J108

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2021

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

n/a

Price

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • AGN - ALLERGAN PLC - SHS is tracked under CUSIP G0177J108.
  • 13F reference-period holder data is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder data for the Q3 2026 reference period is not available.
  • Available periods remain in the history table; they do not substitute for the headline period.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

G0177J108

13F reference period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
30
Headline period
n/a
Rows shown
1-25 of 30
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q2 0 $0 -$2,745,000 0
2021 Q1 15,498 $2,745,000 -$287,000 $177.12 1
2020 Q4 1,536 $287,000 -$15,118,000 $178.97 2
2020 Q3 196,254 $17,480,000 -$112,713,120 $1613.33 2
2020 Q2 255,843 $19,406,000 -$51,805,544,478 $163.56 5
2020 Q1 293,865,499 $52,044,195,146 +$370,839,784 $177.10 862
2019 Q4 290,947,594 $55,620,391,839 +$335,050,978 $191.17 941
2019 Q3 286,674,201 $48,240,241,424 +$2,682,970,884 $168.29 911
2019 Q2 270,458,584 $45,273,072,193 +$1,820,528,032 $167.43 960
2019 Q1 265,286,873 $38,840,874,864 -$107,948,903 $146.41 977
2018 Q4 266,736,015 $35,648,597,017 -$388,196,843 $133.66 984
2018 Q3 266,349,259 $50,726,499,124 +$29,632,457 $190.48 1,057
2018 Q2 266,234,109 $44,391,574,982 -$990,100,536 $166.72 1,028
2018 Q1 271,932,733 $45,756,664,811 +$167,171,927 $168.29 1,011
2017 Q4 271,332,213 $44,381,120,492 -$907,081,369 $163.58 1,033
2017 Q3 272,834,036 $55,902,301,175 -$947,696,817 $204.95 1,080
2017 Q2 276,453,440 $67,202,569,252 -$1,489,608,542 $243.09 1,110
2017 Q1 286,591,405 $68,454,409,489 +$1,317,194,059 $238.92 1,101
2016 Q4 304,650,555 $63,969,267,938 -$5,566,399,064 $210.01 1,084
2016 Q3 329,214,673 $75,790,681,069 -$2,178,699,102 $230.31 1,097
2016 Q2 339,170,898 $78,502,254,922 -$2,142,713,129 $231.09 1,099
2016 Q1 346,461,208 $92,941,423,459 -$1,139,235,515 $268.03 1,100
2015 Q4 349,215,156 $109,248,362,899 -$1,024,540,894 $312.50 1,098
2015 Q3 353,913,203 $96,179,609,331 +$4,058,113,607 $271.81 1,048
2015 Q2 339,500,836 $103,023,655,605 +$102,894,103,002 $303.46 1,020
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .